CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/06/2022
Back to search
Official data from USPTO
MED FUSION CLIN LABS CLIN TRIALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
03/06/2022
Trademark type
Combined
Nice classes
42, 44
Filing date
02/23/2010
Registration date
11/15/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/16/2022
Last transaction
02/16/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/04/2010
First use in commerce
2010-08-00
Drawing code
3
Owner type
16
Owner location
Dallas, TX, US
Examiner
SPARACINO, MARK V
Law office
L30
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of three over-lapping circles, two of them on top, one on the bottom, with the "M" of "MED" inside one of the circles with a line underneath extending from the circle. Underneath the line, there is the word "FUSION". Both "MED" and "FUSION" are in lower case letters. Underneath the word "FUSION" are the hyphenated words "CLIN LABS" and "CLIN TRIALS" in lower case letters separated by a dot.
Holders and representatives
Holders
MED FUSION, LLC
MED FUSION, LLC
XYZ New Company, LLC
Representatives
David J. Davis Baker & McKenzie LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical laboratory services; laboratory research services in the field of personalized medicine; pharmaceutical research and development; consulting services in the field of biotechnologypharmaceutical research and developmentlaboratory testingdiagnostics and pharmacogenetics; medical research; medical scientific researchconducting clinical trials and conducting clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of clinical trials of pharmaceuticals
Class 44
Genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; medical diagnostic testingmonitoring and reporting services for others
Publications
History of USPTO decisions and trademark events.
41 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/06/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/06/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/16/2022
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/16/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/16/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/16/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
09/10/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
06/07/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/07/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/26/2018
E815
TEAS SECTION 8 & 15 RECEIVED
05/15/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/15/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/19/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/19/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/15/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
10/13/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
10/12/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/04/2011
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/03/2011
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/29/2011
IUAF
USE AMENDMENT FILED
09/28/2011
EISU
TEAS STATEMENT OF USE RECEIVED
09/28/2011
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/29/2011
PUBO
PUBLISHED FOR OPPOSITION
02/01/2011
NPUB
NOTICE OF PUBLICATION
01/12/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/29/2010
ALIE
ASSIGNED TO LIE
12/29/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2010
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/15/2010
CNRT
NON-FINAL ACTION MAILED
06/02/2010
CNRT
NON-FINAL ACTION WRITTEN
06/01/2010
DOCK
ASSIGNED TO EXAMINER
05/26/2010
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
03/02/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2010
NWAP
NEW APPLICATION ENTERED
02/26/2010
Continuous trademark protection
Get notified about every new filing that threatens MED FUSION CLIN LABS CLIN TRIALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.